Myeloma Crowd Radio: Noopur Raje, MD, Massachusetts General Hospital
  • 16/04/2021
  • 7
  • 0
  • 0

Myeloma Crowd Radio: Noopur Raje, MD, Massachusetts General Hospital

Audio no disponible. Inténtalo más tarde.
  • Descargar
  • Compartir
  • Me gusta
  • Más
    • Escuchar en popup
    • Denunciar Contenido
Preparando para la descarga

Preparando audio para descarga.

Escucha patrocinada. El audio empezará en pocos segundos...

Escucha sin anuncios y sin esperas con iVoox Premium

Pruébalo Gratis

X

Descripción de Myeloma Crowd Radio: Noopur Raje, MD, Massachusetts General Hospital

CAR T therapy has been in development for over 20 years. The first CAR T therapy is now available for the treatment of multiple myeloma. The ide-cel treatment (now called Abecma) is now FDA approved for multiple myeloma relapsed or refractory patients. In this show, Dr. Noopur Raje of Mass General Hospital will share how the CAR T cell therapy works, outcome data from clinical trials, a review of patients who are eligible to join and when patients should consider the therapy in context of other therapies. Ide-cel (Abecma) is a product developed by Bristol Myers Squibb and blubird bio. Thanks to our episode sponsor, Oncopeptides

Mostrar Ocultar

multiple myeloma myeloma Massachusetts General Hospita noopur raje CAR T

Comentarios

Por decisión del propietario, no se aceptan comentarios anónimos. Registrate para comentarlo.

Más de Mente y psicología

VER TODOS